Interpace Biosciences, Inc. (IDXG)

7.25 +375.41% (+5.72)

Over 3Y: +457.7%

2026-08-27
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 4 6
2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 8.1M Q3 '21 — Operating Cash Flow: -676K Q3 '21 — Free Cash Flow: -820K Q3 '21 — Net Income: -3.6M Q4 '21 — Revenue: 9.1M Q4 '21 — Operating Cash Flow: -1.2M Q4 '21 — Free Cash Flow: -1.4M Q4 '21 — Net Income: -3.7M Q1 '22 — Revenue: 7.9M Q1 '22 — Operating Cash Flow: -1.3M Q1 '22 — Free Cash Flow: -1.3M Q1 '22 — Net Income: -2.2M Q2 '22 — Revenue: 7.4M Q2 '22 — Operating Cash Flow: -2.9M Q2 '22 — Free Cash Flow: -3M Q2 '22 — Net Income: -3.9M Q3 '22 — Revenue: 8.2M Q3 '22 — Operating Cash Flow: -3.2M Q3 '22 — Free Cash Flow: -3.3M Q3 '22 — Net Income: -14.2M Q4 '22 — Revenue: 8.3M Q4 '22 — Operating Cash Flow: -276K Q4 '22 — Free Cash Flow: -472K Q4 '22 — Net Income: -1.6M Q1 '23 — Revenue: 9.8M Q1 '23 — Operating Cash Flow: 1.1M Q1 '23 — Free Cash Flow: 1.1M Q1 '23 — Net Income: 351K Q2 '23 — Revenue: 11M Q2 '23 — Operating Cash Flow: 411K Q2 '23 — Free Cash Flow: 300K Q2 '23 — Net Income: 175K Q3 '23 — Revenue: 9.1M Q3 '23 — Operating Cash Flow: 1.1M Q3 '23 — Free Cash Flow: 953K Q3 '23 — Net Income: -614K Q4 '23 — Revenue: 10.1M Q4 '23 — Operating Cash Flow: 1.1M Q4 '23 — Free Cash Flow: 998K Q4 '23 — Net Income: 1.1M Q1 '24 — Revenue: 10.2M Q1 '24 — Operating Cash Flow: -58K Q1 '24 — Free Cash Flow: -86K Q1 '24 — Net Income: 708K Q2 '24 — Revenue: 12M Q2 '24 — Operating Cash Flow: 1.4M Q2 '24 — Free Cash Flow: 1.2M Q2 '24 — Net Income: 2.4M Q3 '24 — Revenue: 12.3M Q3 '24 — Operating Cash Flow: 2.1M Q3 '24 — Free Cash Flow: 1.6M Q3 '24 — Net Income: 1.7M Q4 '24 — Revenue: 12.4M Q4 '24 — Operating Cash Flow: 1.2M Q4 '24 — Free Cash Flow: 1.1M Q4 '24 — Net Income: 1.9M Q1 '25 — Revenue: 11.5M Q1 '25 — Operating Cash Flow: 1.2M Q1 '25 — Net Income: 1.6M Q2 '25 — Revenue: 9.2M Q2 '25 — Operating Cash Flow: 520K Q2 '25 — Net Income: -640K Q3 '25 — Revenue: 8.8M Q3 '25 — Operating Cash Flow: 1.9M Q3 '25 — Free Cash Flow: 1.8M Q3 '25 — Net Income: 911K Q4 '25 — Revenue: 9.2M Q4 '25 — Operating Cash Flow: 2.1M Q4 '25 — Free Cash Flow: 2.1M Q4 '25 — Net Income: 22.7M Q1 '26 — Revenue: 9M Q1 '26 — Operating Cash Flow: 283K Q1 '26 — Free Cash Flow: 142K Q1 '26 — Net Income: 721K Q2 '26 — Revenue: 9.1M Q2 '26 — Operating Cash Flow: 98K Q2 '26 — Free Cash Flow: 41K Q2 '26 — Net Income: 158K -8M 0 8M 16M 24M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

4.5
SBC / sales 0.053%
OE margin 11.3%
Oper. margin 11.5%
ROIC 16.1%
ROA 70.8%
ROE 105.2%
Gross margin 63.7%
ROCE 14.1%
FCF margin 11.4%
OCF margin 12.3%
OCF / EBIT 1.1×
Accruals 57.9%

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.3
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

8.5
ND/EBITDA —
Debt / Eq 0.0×
Debt payback 0.0 yr
Payout 0.0%
Quick ratio 2.0×
F-score 4.5 pts
Cash / Debt —
Cash runway —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

3.3
Sales/sh Y/Y -54.8%
EPS Y/Y +204.2%
EBIT Y/Y -27.2%
Sales Q/Q -1.1%
Shares change +76.1%
Div. growth —
EBIT CAGR —
EPS CAGR 4Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.